Some Statistical and Regulatory Issues in the Evaluation of Genetic and Genomic Tests-Reference-Cited by-同舟云学术

Some Statistical and Regulatory Issues in the Evaluation of Genetic and Genomic Tests

Published:2004-12-29 Issue:3 Volume:14 Page:539-552
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Campbell Gregory¹²

Affiliation:

1. a Division of Biostatistics , Center for Devices and Radiological Health , U.S. Food and Drug Administration , Rockville, Maryland, USA

2. b Division of Biostatistics , Center for Devices and Radiological Health , U.S. Food and Drug Administration , 1350 Piccard Drive, HFZ-542, Rockville, MD, 20850, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1081/BIP-200025645

Reference41 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2. Biases in the assessment of diagnostic tests

3. Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative

4. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Devices;Wiley StatsRef: Statistics Reference Online;2018-02-15

2. Statistical innovations in the medical device world sparked by the FDA;Journal of Biopharmaceutical Statistics;2015-09-15

3. Clinical and Evidence-Based Research in the Clinical Laboratory;Clinical Laboratory Management;2014-10-30

4. Expression Tests in Actual Clinical Practice: How Medically Useful is the Transcriptome?;Transcriptomics in Health and Disease;2014

5. CHAPTER 12. Discovery and Validation Case Studies, Recommendations: Bottlenecks in Biomarker Discovery and Validation by Using Proteomic Technologies;Drug Discovery;2013